| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |